Macrogenics (MGNX) Misses Q1 EPS by 1c May 13, 2026 04:03PM
MacroGenics to sell manufacturing operations to Bora for $122.5 million May 11, 2026 05:22PM
Macrogenics (MGNX) Halted, News Pending May 11, 2026 04:25PM
MacroGenics expands ZYNYZ royalty deal with Sagard for $60 million May 4, 2026 07:31AM
B.Riley Upgrades MacroGenics (MGNX) to Buy, 'uniquely situated' Apr 10, 2026 06:59AM


Apr 8, 2026 04:30PM FDA lifts partial clinical hold on MacroGenics' cancer drug study
Mar 10, 2026 05:03PM Stifel Reiterates Hold Rating on MacroGenics (MGNX): "MGC026 dose-escalation/expansion data should read well"
Feb 24, 2026 04:29AM MacroGenics (MGNX) Reiterated at Market Perform by Citizens; Regroups Under New CEO
Nov 20, 2025 04:03PM MacroGenics CMO Stephen Eck to depart company at year-end
Nov 12, 2025 04:22PM Macrogenics (MGNX) Tops Q3 EPS by 68c, provides cash runway guidance
Sep 17, 2025 04:39AM Barclays Starts MacroGenics (MGNX) at Overweight
Aug 15, 2025 06:00AM Citizens JMP Reiterates Market Perform Rating on MacroGenics (MGNX)
Aug 14, 2025 04:03PM Macrogenics (MGNX) Misses Q2 EPS by 11c, Misses on Revenue
Jun 11, 2025 07:16AM Stifel Reiterates Hold Rating on MacroGenics (MGNX)
Jun 11, 2025 04:25AM Citizens JMP Reiterates Market Perform Rating on MacroGenics (MGNX)
Jun 10, 2025 07:07AM Macrogenics (MGNX) and Sagard Healthcare Partners Enter into ZYNYZ Royalty Purchase Agreement
May 28, 2025 04:25AM Citizens JMP shares updates on cancer treatment stocks
May 14, 2025 09:22AM MacroGenics (MGNX) PT Lowered to $5 at Stifel
May 13, 2025 04:12PM Macrogenics (MGNX) Reports In-Line Q1 EPS
Mar 25, 2025 06:48AM MacroGenics (MGNX) PT Lowered to $2 at H.C. Wainwright
Mar 21, 2025 07:48AM Stifel Reiterates Hold Rating on MacroGenics (MGNX)
Mar 21, 2025 04:39AM Citizens JMP Reiterates Market Outperform Rating on MacroGenics (MGNX)
Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview
Nov 5, 2024 04:03PM Macrogenics (MGNX) Tops Q3 EPS by 69c, Beats on Revenue
Oct 30, 2024 07:30AM Macrogenics (MGNX) Announces CEO Departure
Oct 22, 2024 07:30AM Macrogenics (MGNX) Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA
Sep 18, 2024 06:42AM H.C. Wainwright Reiterates Neutral Rating on MacroGenics (MGNX)
Sep 16, 2024 08:56AM TD Cowen Reiterates Hold Rating on MacroGenics (MGNX)
Aug 21, 2024 06:44AM H.C. Wainwright Reiterates Neutral Rating on MacroGenics (MGNX)
Aug 7, 2024 10:18AM MacroGenics (MGNX) PT Lowered to $6 at Stifel
Aug 7, 2024 09:23AM MacroGenics (MGNX) PT Lowered to $5 at BMO Capital
Aug 6, 2024 04:52PM Macrogenics (MGNX) Misses Q2 EPS by 23c
Jul 31, 2024 04:18PM BTIG Downgrades MacroGenics (MGNX) to Neutral
Jul 31, 2024 03:21AM B.Riley Downgrades MacroGenics (MGNX) to Neutral
Jul 31, 2024 02:28AM Guggenheim Downgrades MacroGenics (MGNX) to Neutral
Jul 30, 2024 04:11PM Macrogenics (MGNX) Provides Vobramitamab Duocarmazine Update
Jul 30, 2024 04:01PM Macrogenics (MGNX) Achieves $100M in Milestones Related to Retifanlimab Collaboration with Incyte